<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>REID, DEBORAH Progress Note</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body><h1 class="h1center">REID, DEBORAH Progress Note</h1><table class="header_table"><tr><td class="td_header_role_name"><span class="td_label">Patient</span></td><td class="td_header_role_value">DEBORAH L REID</td></tr><tr><td class="td_header_role_name"><span class="td_label">Date of birth</span></td><td class="td_header_role_value">December 31, 1959 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Current Gender</span></td><td class="td_header_role_value">Female</td></tr><tr><td class="td_header_role_name"><span class="td_label">Race(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>WHITE</li><li>White</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Ethnicity</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>NOT HISPANIC OR LATINO</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Language(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>English</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Primary Home Address:<br/>7495 WEST CHARLESTON BLVD<br/>APT. 49<br/>LAS VEGAS, NV 89117<br/><br/>Mobile Phone:  (702)904-2886<br/>Primary Home Phone:  (505)660-6653<br/>Work Phone:  702 304-8338<br/>Primary Home Phone:  (505)660-6653<br/>Mobile Phone:  (702)904-2886<br/>Email:  DLAREID@HOTMAIL.COM<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Patient IDs</span></td><td class="td_header_role_value">686932 2.16.840.1.113883.3.623<br/></td></tr></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document Id</span></td><td class="td_header_role_value">ProgressNote_REID_20240801_1315_40.331 2.16.840.1.113883.3.623</td></tr><tr><td class="td_header_role_name"><span class="td_label">Document Created:</span></td><td class="td_header_role_value">August 1, 2024, 13:15:40, MST </td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Performer </span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Anu Thummala of Comprehensive Cancer Center of Nevada</td></tr><tr><td class="td_header_role_value internal_format"><br/><br/><br/></td></tr></tbody></table></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Author</span></td><td class="td_header_role_value">G2Carequality Interface, Comprehensive Cancer Center of Nevada</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">Siena Stephanie Horizon Ridge Twain<br/>Summerlin Southern Hills Northwest<br/>Las Vegas, NV 89128<br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Encounter Id</span></td><td class="td_header_role_value">9937012 2.16.840.1.113883.19</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Type</span></td><td class="td_header_role_value">OFFICE/OUTPATIENT ESTABLISHED MOD MDM 30 MIN</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Date</span></td><td class="td_header_role_value"> From January 2, 2024  to January 2, 2024 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Location</span></td><td class="td_header_role_value"/></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Informant</span></td><td class="td_header_role_value">Anu Thummala of Comprehensive Cancer Center of Nevada</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document maintained by</span></td><td class="td_header_role_value">McKesson Specialty Health</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">10101 Woodloch Forest<br/>The Woodlands, TX 77380, USA<br/><br/>Work Phone:  800 381 2637<br/></td></tr></tbody></table><h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Assessment</a></li><li><a href="#id2">Allergies and Adverse Reactions</a></li><li><a href="#id3">Plan</a></li><li><a href="#id4">Reason for Visit</a></li><li><a href="#id5">Encounters</a></li><li><a href="#id6">Immunizations</a></li><li><a href="#id7">Diagnostic Results</a></li><li><a href="#id8">Medications</a></li><li><a href="#id9">Problems</a></li><li><a href="#id10">Vital Signs</a></li><li><a href="#id11">Notes Section</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Assessment</a></h3><div>See Clinical Notes section</div><h3><a name="id2" href="#toc">Allergies and Adverse Reactions</a></h3><div><table>
    <thead>
        <tr>
                            <th>Medication/Group Name</th>
                <th>Reaction</th>
                <th>Severity</th>
                <th>Date</th>
        </tr>
    </thead>
    <tbody>
                <tr ID="AlertOBS-1000">
                            <td>Sulfa (Sulfonamide Antibiotics)</td>
                            <td>Hives, no mappable FDB reaction</td>
                            <td/>
                            <td>11/17/2022</td>
                </tr>
    </tbody>
</table>
</div><h3><a name="id3" href="#toc">Plan</a></h3><div><table>
	<thead>
		<tr>
							<th>Date</th>
				<th>Type</th>
				<th>Value</th>
		</tr>
	</thead>
	<tbody>
				<tr ID="CarePlanRef-1001">
						<td>01/19/2024</td>
						<td>APPOINTMENT</td>
						<td>PT INR 15 MIN</td>
				</tr>
				<tr ID="CarePlanRef-1002">
						<td>01/02/2024</td>
						<td>APPOINTMENT</td>
						<td>OV 15 MIN</td>
				</tr>
				<tr ID="CarePlanRef-1003">
						<td>01/02/2024</td>
						<td>LABORDER</td>
						<td>CT chest/abdomen/pelvis w/ contrast</td>
				</tr>
				<tr ID="CarePlanRef-1004">
						<td>01/02/2024</td>
						<td>LABORDER</td>
						<td>MRI breast w/ contrast</td>
				</tr>
				<tr ID="CarePlanRef-1005">
						<td>01/02/2024</td>
						<td>LABORDER</td>
						<td>DEXA scan</td>
				</tr>
				<tr ID="CarePlanRef-1006">
						<td>01/02/2024</td>
						<td>LABORDER</td>
						<td>PT INR panel</td>
				</tr>
				<tr ID="CarePlanRef-1007">
						<td>01/15/2024</td>
						<td>LABORDER</td>
						<td>PT INR panel</td>
				</tr>
				<tr ID="CarePlanRef-1008">
						<td>01/19/2024</td>
						<td>LABORDER</td>
						<td>PT/PTT panel</td>
				</tr>
				<tr ID="CarePlanRef-1009">
						<td>01/19/2024</td>
						<td>LABORDER</td>
						<td>PT INR panel</td>
				</tr>
				<tr ID="CarePlanRef-1010">
						<td>01/19/2024</td>
						<td>LABORDER</td>
						<td>PT/PTT panel</td>
				</tr>
	</tbody>
</table>
</div><h3><a name="id4" href="#toc">Reason for Visit</a></h3><div>PT INR 15 MIN</div><h3><a name="id5" href="#toc">Encounters</a></h3><div><table>
	<thead>
		<tr>
							<th>Date</th>
				<th>Name</th>
		</tr>
	</thead>
	<tbody>
					<tr ID="EncounterDiagnosisRef-1011">
							<td>01/02/2024</td>
							<td>Primary malignant neoplasm of female breast (disorder)</td>						
					</tr>
	</tbody>
</table>
</div><h3><a name="id6" href="#toc">Immunizations</a></h3><div><table>
	<thead>
		<tr>
							<th>Date</th>
				<th>Name</th>
				<th>Route</th>
				<th>Dose</th>
				<th>Instructions</th>
				<th>Refusal Reason</th>
				<th>Status</th>
		</tr>
	</thead>
	<tbody>
				<tr><td colspan="7">No data for this encounter</td></tr>
	</tbody>
</table>
</div><h3><a name="id7" href="#toc">Diagnostic Results</a></h3><div><table>
	<thead>
		<tr>
							<th>Date</th>
				<th>Type</th>
				<th>Test</th>
				<th>Units</th>
				<th>Lower Limit</th>
				<th>Upper Limit</th>
				<th>Result</th>
				<th>Flag</th>
				<th>Comments</th>
				<th>Status</th>
				<th>Ordered By</th>
				<th>Specimen Source</th>
				<th>Lab Address</th>
		</tr>
	</thead>
	<tbody>
				<tr ID="ResultOBS-1012">
						<td>01/19/2024</td>
						<td>PT INR panel</td>
						<td>PT</td>
						<td>seconds</td>
						<td>10.8</td>
						<td>13.3</td>
						<td>56.0</td>
						<td>High</td>
						<td/>
						<td>FINAL</td>
						<td>Anu Thummala</td>
                        <td/>
                        <td>NORTHWEST, 7445 Peak Drive LAS VEGAS NV 891280000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1013">
						<td>01/19/2024</td>
						<td>PT INR panel</td>
						<td>INR</td>
						<td/>
						<td>0.72</td>
						<td>1.12</td>
						<td>4.70</td>
						<td>High</td>
						<td/>
						<td>FINAL</td>
						<td>Anu Thummala</td>
                        <td/>
                        <td>NORTHWEST, 7445 Peak Drive LAS VEGAS NV 891280000  Edwin Kingsley </td>
				</tr>
				<tr ID="ResultOBS-1014">
						<td>01/19/2024</td>
						<td/>
						<td>MR BREAST BILAT W/WO CONTRAST</td>
						<td/>
						<td/>
						<td/>
						<td>See attached</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Anu Thummala</td>
                        <td/>
                        <td/>
				</tr>
				<tr ID="ResultOBS-1015">
						<td>01/19/2024</td>
						<td/>
						<td>CT CHEST W CONTRAST</td>
						<td/>
						<td/>
						<td/>
						<td>See attached</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Anu Thummala</td>
                        <td/>
                        <td/>
				</tr>
				<tr ID="ResultOBS-1016">
						<td>01/19/2024</td>
						<td/>
						<td>CT AB PE W CONTRAST</td>
						<td/>
						<td/>
						<td/>
						<td>See attached</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Anu Thummala</td>
                        <td/>
                        <td/>
				</tr>
				<tr ID="ResultOBS-1017">
						<td>01/19/2024</td>
						<td>PT INR panel</td>
						<td>Target INR</td>
						<td/>
						<td/>
						<td/>
						<td>2-3</td>
						<td/>
						<td/>
						<td/>
						<td/>
                        <td>Blood</td>
                        <td/>
				</tr>
				<tr ID="ResultOBS-1018">
						<td>01/19/2024</td>
						<td>PT INR panel</td>
						<td>Current Warfarin dose</td>
						<td/>
						<td/>
						<td/>
						<td>7.5 mg x 1; 5 mg rest </td>
						<td/>
						<td/>
						<td/>
						<td/>
                        <td>Blood</td>
                        <td/>
				</tr>
				<tr ID="ResultOBS-1019">
						<td>01/19/2024</td>
						<td>PT INR panel</td>
						<td>New Warfarin dose</td>
						<td/>
						<td/>
						<td/>
						<td>see note </td>
						<td/>
						<td/>
						<td/>
						<td/>
                        <td>Blood</td>
                        <td/>
				</tr>
				<tr ID="ResultOBS-1020">
						<td>01/19/2024</td>
						<td>PT INR panel</td>
						<td>PT INR lab result note</td>
						<td/>
						<td/>
						<td/>
						<td>Pt reports having some issues and has changed her diet.  She will hold for 2 days and resume as previous dose per her request. </td>
						<td/>
						<td/>
						<td/>
						<td/>
                        <td>Blood</td>
                        <td/>
				</tr>
				<tr ID="ResultOBS-1021">
						<td>01/26/2024</td>
						<td/>
						<td>BD DX SCAN SPINE HIPS</td>
						<td/>
						<td/>
						<td/>
						<td>See attached</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td>Anu Thummala</td>
                        <td/>
                        <td/>
				</tr>
	</tbody>
</table>
</div><h3><a name="id8" href="#toc">Medications</a></h3><div><table>
	<thead>
		<tr>
							<th>Date</th>
				<th>Name</th>
				<th>Route</th>
				<th>Dose</th>
				<th>Frequency</th>
				<th>Instructions</th>
				<th>Start Date</th>
				<th>End Date</th>
				<th>Status</th>
		</tr>
	</thead>
	<tbody>
					<tr ID="MedicationOBS-1022">
							<td>07/16/2024</td>
							<td>apixaban 5 MG Oral Tablet [Eliquis] </td>
							<td>orally</td>
							<td>1.0 tablet</td>
							<td>2 times per day</td>
							<td/>
							<td>07/16/2024</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1023">
							<td>07/03/2024</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>07/03/2024</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1024">
							<td>06/03/2024</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>06/03/2024</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1025">
							<td>05/28/2024</td>
							<td>cholecalciferol 0.125 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>05/28/2024</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1026">
							<td>05/28/2024</td>
							<td>cholecalciferol 0.125 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>05/28/2024</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1027">
							<td>05/01/2024</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>05/01/2024</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1028">
							<td>04/22/2024</td>
							<td>cholecalciferol 0.125 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>04/22/2024</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1029">
							<td>04/04/2024</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>04/04/2024</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1030">
							<td>03/04/2024</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>03/04/2024</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1031">
							<td>02/02/2024</td>
							<td>cholecalciferol 0.125 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>02/02/2024</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1032">
							<td>02/02/2024</td>
							<td>cholecalciferol 0.125 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>02/02/2024</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1033">
							<td>02/02/2024</td>
							<td>cholecalciferol 0.125 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>02/02/2024</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1034">
							<td>11/08/2023</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>11/08/2023</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1035">
							<td>10/10/2023</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>10/10/2023</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1036">
							<td>09/11/2023</td>
							<td>cholecalciferol 0.125 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>09/11/2023</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1037">
							<td>09/11/2023</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>09/11/2023</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1038">
							<td>08/11/2023</td>
							<td>cholecalciferol 0.125 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>08/11/2023</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1039">
							<td>08/11/2023</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>08/11/2023</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1040">
							<td>07/13/2023</td>
							<td>cholecalciferol 0.125 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>07/13/2023</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1041">
							<td>07/13/2023</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>07/13/2023</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1042">
							<td>06/12/2023</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>06/12/2023</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1043">
							<td>04/17/2023</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>04/17/2023</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1044">
							<td>04/17/2023</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>04/17/2023</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1045">
							<td>03/14/2023</td>
							<td>cholecalciferol 0.125 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>03/14/2023</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1046">
							<td>02/13/2023</td>
							<td>cholecalciferol 0.125 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>02/13/2023</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1047">
							<td>12/14/2022</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>12/14/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1048">
							<td>11/17/2022</td>
							<td>cholecalciferol 0.125 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>11/17/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1049">
							<td>08/23/2022</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>08/23/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1050">
							<td>08/23/2022</td>
							<td>cholecalciferol 0.125 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>08/23/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1051">
							<td>05/02/2022</td>
							<td>cholecalciferol 0.125 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>05/02/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1052">
							<td>04/29/2022</td>
							<td>Famotidine Oral </td>
							<td>PO</td>
							<td>1.0 TABLET(S)</td>
							<td>QHS</td>
							<td/>
							<td>04/29/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1053">
							<td>04/29/2022</td>
							<td>Lisinopril Oral </td>
							<td>PO</td>
							<td>1.0 TABLET(S)</td>
							<td>daily</td>
							<td/>
							<td>04/29/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1054">
							<td>04/29/2022</td>
							<td>Hydrocodone-Acetaminophen Oral 5 mg-325 mg </td>
							<td>PO</td>
							<td>1.0 TABLET(S)</td>
							<td>Q4H PRN pain</td>
							<td/>
							<td>04/29/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1055">
							<td>04/29/2022</td>
							<td>Levothyroxine Oral </td>
							<td>PO</td>
							<td>1.0 TABLET(S)</td>
							<td>daily</td>
							<td/>
							<td>04/29/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1056">
							<td>04/29/2022</td>
							<td>Sertraline Oral </td>
							<td>PO</td>
							<td>2.0 TABLET(S)</td>
							<td>daily</td>
							<td/>
							<td>04/29/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1057">
							<td>03/30/2022</td>
							<td>cholecalciferol 0.125 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>03/30/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1058">
							<td>03/28/2022</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>03/28/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1059">
							<td>11/02/2021</td>
							<td>cholecalciferol 0.125 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>11/02/2021</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1060">
							<td>09/28/2021</td>
							<td>cholecalciferol 0.125 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>09/28/2021</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1061">
							<td>06/14/2021</td>
							<td>cholecalciferol 0.125 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>06/14/2021</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1062">
							<td>03/26/2021</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td/>
							<td/>
							<td>03/26/2021</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1063">
							<td>03/25/2021</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td/>
							<td/>
							<td>03/25/2021</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1064">
							<td>03/25/2021</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>03/25/2021</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1065">
							<td>02/18/2021</td>
							<td>cholecalciferol 0.125 MG Oral Tablet </td>
							<td>orally</td>
							<td>125.0 mcg</td>
							<td/>
							<td/>
							<td>02/18/2021</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1066">
							<td>10/26/2020</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>10/26/2020</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1067">
							<td>06/29/2020</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>06/29/2020</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1068">
							<td>02/14/2020</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>02/14/2020</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1069">
							<td>05/29/2019</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>05/29/2019</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1070">
							<td>10/01/2018</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>10/01/2018</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1071">
							<td>05/15/2018</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>05/15/2018</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1072">
							<td>12/01/2017</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>12/01/2017</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1073">
							<td>10/20/2017</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>10/20/2017</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1074">
							<td>05/30/2017</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>05/30/2017</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1075">
							<td>02/15/2017</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>02/15/2017</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1076">
							<td>10/27/2016</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>10/27/2016</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1077">
							<td>10/27/2016</td>
							<td>Warfarin Oral </td>
							<td>PO</td>
							<td>1.0 TABLET(S)</td>
							<td>daily</td>
							<td/>
							<td>10/27/2016</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1078">
							<td>05/12/2016</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>05/12/2016</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1079">
							<td>02/05/2016</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>02/05/2016</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1080">
							<td>10/22/2015</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>10/22/2015</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1081">
							<td>08/13/2015</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>08/13/2015</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1082">
							<td>05/21/2015</td>
							<td>letrozole 2.5 MG Oral Tablet </td>
							<td>orally</td>
							<td>1.0 tablet(s)</td>
							<td/>
							<td/>
							<td>05/21/2015</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1083">
							<td>09/11/2014</td>
							<td>Lovastatin Oral </td>
							<td>PO</td>
							<td>1.0 TABLET(S)</td>
							<td>daily with evening meals</td>
							<td/>
							<td>09/11/2014</td>
							<td/>
							<td>active</td>
					</tr>
	</tbody>
</table>
</div><h3><a name="id9" href="#toc">Problems</a></h3><div><table>
	<thead>
		<tr>
							<th>Diagnosis</th>
				<th>Status</th>
				<th>Date of Diagnosis</th>
		</tr>
	</thead>
	<tbody>
				<tr ID="ProblemOBS-1084">
						<td>Easy bruising</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1085">
						<td>Primary malignant neoplasm of female breast (disorder)</td>
						<td>Active</td>
						<td>08/19/2014</td>
				</tr>
				<tr ID="ProblemOBS-1086">
						<td>Family history of cancer (situation)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1087">
						<td>Deep venous thrombosis (disorder)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1088">
						<td>Family history of prostate cancer (situation)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1089">
						<td>Solitary nodule of lung (finding)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1090">
						<td>BRCA2 gene mutation positive (finding)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1091">
						<td>Abscess of breast (disorder)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1092">
						<td>Anemia (disorder)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1093">
						<td>Mammography abnormal (finding)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1094">
						<td>Anxiety attack (finding)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1095">
						<td>Fatigue (finding)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1096">
						<td>Vitamin D deficiency (disorder)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1097">
						<td>Anxiety (finding)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1098">
						<td>Screening for osteoporosis (procedure)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1099">
						<td>Encounter for nonprocreative screening for genetic disease carrier status</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1100">
						<td>Estrogen receptor positive status [ER+]</td>
						<td>Active</td>
						<td/>
				</tr>
	</tbody>
</table>
</div><h3><a name="id10" href="#toc">Vital Signs</a></h3><div><table>
	<thead>
		<tr>
							<th>Date</th>
				<th>Type</th>
				<th>Value</th>
		</tr>
	</thead>
	<tbody>
				<tr ID="VitalSignsRef-1101">
						<td>01/02/2024</td>
						<td>
							Body Temperature
							
						</td>
						<td>97.30</td>
				</tr>
				<tr ID="VitalSignsRef-1102">
						<td>01/02/2024</td>
						<td>
							Heart Beat
							
						</td>
						<td>81.00</td>
				</tr>
				<tr ID="VitalSignsRef-1103">
						<td>01/02/2024</td>
						<td>
							Respiratory Rate
							
						</td>
						<td>16.00</td>
				</tr>
				<tr ID="VitalSignsRef-1104">
						<td>01/02/2024</td>
						<td>
							Oxygen Saturation
							
						</td>
						<td>98.00</td>
				</tr>
				<tr ID="VitalSignsRef-1105">
						<td>01/02/2024</td>
						<td>
							BSA
							
						</td>
						<td>1.93</td>
				</tr>
				<tr ID="VitalSignsRef-1106">
						<td>01/02/2024</td>
						<td>
							Pain Scale
							
						</td>
						<td>0.00</td>
				</tr>
				<tr ID="VitalSignsRef-1107">
						<td>01/02/2024</td>
						<td>
							Weight
							
						</td>
						<td>211.00</td>
				</tr>
				<tr ID="VitalSignsRef-1108">
						<td>01/02/2024</td>
						<td>
							Height
							
						</td>
						<td>61.00</td>
				</tr>
				<tr ID="VitalSignsRef-1109">
						<td>01/02/2024</td>
						<td>
							BMI
							
						</td>
						<td>39.87</td>
				</tr>
				<tr ID="VitalSignsRef-1110">
						<td>01/02/2024</td>
						<td>
							Intravascular Systolic
							
						</td>
						<td>113</td>
				</tr>
				<tr ID="VitalSignsRef-1111">
						<td>01/02/2024</td>
						<td>
							Intravascular Diastolic
							
						</td>
						<td>77</td>
				</tr>
	</tbody>
</table>
</div><h3><a name="id11" href="#toc">Notes Section</a></h3><div>	<ul><li>
		        Follow Up Note - Thummala: 
		        <p>
		        		
<br/>
7445 Peak Drive<br/>
Las Vegas, NV 89128<br/>
P: 702-952-2140 F: 702-952-2180<br/>
<br/>

<br/>
PATIENT: DEBORAH REID

<br/>MRN: 686932

<br/>DATE: 01/02/2024

<br/>DOB: 12/31/1959

<br/>ATTENDING PHYSICIAN: Anu Thummala, MD

<br/>
FOLLOW-UP NOTE<br/>
<br/>

<ul><li>Primary malignant neoplasm of female breast (disorder) ( Stage Date: 09/11/2014, Stage IIA (Left breast upper-outer quadrant, T2, pN0, M0, G3, ER Status: Positive, PR Status: Negative)<br/>
	Date of Dx:08/19/2014 ; ICD-10:C50.412 ;Malignant neoplasm of upper-outer quadrant of left female breast )</li></ul>
<br/>
<br/> CURRENT STATUS~ <br/>
Patient is here for a follow up. She remains on letrozole and tolerates it well. She denies any bleeding complications with warfarin. Labs were reviewed.<br/>
Lost to follow-up x one year<br/>
On monthly PT/INR monitoring<br/>
<br/>
<br/> DIAGNOSIS~ <br/>
Primary malignant neoplasm of female breast<br/>


<br/> HISTORY OF PRESENT ILLNESS~ 

<br/>
<br/>
<br/>Completed Adriamycin/Cytoxan Q 3 weeks for four cycles and weekly Taxol with Neupogen in May 2015. Deborah is also followed by Dr Williams and her mammogram in December 2018 was BI-RADS category 4 and was followed by a breast ultrasound which showed micro calcifications. She underwent a core biopsy which was benign.<br/>
<br/>
She remains on letrozole since May 2015. No recent fractures. She continues warfarin with no bleeding complications, mild elevated INR followed by Cardiology<br/>
She recently completed genetic counseling for BRCA 2 mutation and decided against mastectomy. Improved depression. She decided against mastectomy.

<br/>
<br/> PAST MEDICAL HISTORY~ <br/>
<br/>
<br/>
<br/> PAST SURGICAL HISTORY~ <br/>
Two lumpectomies and cholecystectomy.<br/>
<br/>
<br/> SOCIAL HISTORY~ <br/>
Denies any tobacco abuse.  She drinks two alcoholic beverages per week.  Currently employed in a dental office. <br/>
<br/>
<br/> CURRENT MEDICATIONS~ <br/>

<ul><li>Vitamin D3 (Cholecalciferol Oral) 125 mcg (5,000 unit) tablet</li><li>Letrozole Oral 2.5 mg tablet</li><li>Cyclobenzaprine Oral 5 mg tablet</li><li>Lovastatin Oral 20 mg tablet</li><li>Hydrocodone-Acetaminophen Oral 5 mg-325 mg 5-325 mg tablet</li><li>Levothyroxine Oral 125 mcg tablet</li><li>Sertraline Oral 100 mg tablet</li><li>Warfarin Oral 6 mg tablet</li><li>Lisinopril Oral 10 mg tablet</li><li>Carisoprodol Oral 350 mg tablet</li><li>Letrozole 2.5 mg tablet</li><li>Warfarin Oral 5 mg tablet</li><li>Cholecalciferol 125 mcg (5,000 unit) tablet</li><li>Famotidine Oral 20 mg tablet</li></ul>
<br/>
<br/>
<br/> ALLERGIES~ <br/>

<ul><li>Sulfa (Sulfonamide Antibiotics)</li></ul>
<br/>
<br/>
<br/> FAMILY HISTORY~ <br/>
<br/>
<br/>
<br/> OB/GYN HISTORY~ <br/>
<br/>
<br/>
<br/> CODE STATUS~ <br/>
<br/>
<br/>
<br/> PALLIATIVE CARE~ <br/>
<br/>
<br/>
<br/> REVIEW OF SYSTEMS~ <br/>
reviewed<br/>
CONSTITUTIONAL:  Weight loss stable and some night sweats.<br/>
HEENT:  History of migraine headaches.<br/>
CARDIOVASCULAR:  Hypertension.<br/>
RESPIRATORY:  Unremarkable.<br/>
GASTROINTESTINAL:  Unremarkable.<br/>
GU:  Unremarkable.  Pap smear was in 2014.<br/>
MUSCULOSKELETAL:  Arthritis and back pain.<br/>
NEUROLOGIC:  Unremarkable.  No history of stroke.<br/>
HEMATOLOGIC:  anemia<br/>
ENDOCRINE:  Thyroid disease and hypercholesterolemia.<br/>
PSYCHIATRIC:  Unremarkable. anxiety<br/>


<br/> PHYSICAL EXAM~ <br/>
<br/>HEENT:  Examination shows no icterus.  No palpable adenopathy.  Oropharynx is clear. resolved alopecia<br/>
CARDIOVASCULAR:  First and second heart sounds are heard.<br/>
LUNGS:  Clear to auscultation.<br/>
BREAST: Lumpectomy changes in left breast with large scar in the axilla. Left nipple is slightly inverted. Right breast in dense. Nipple is normal with no discharge. No adenopathy.<br/>
Lymph nodes are negative.  No nipple discharge is noted.<br/>
ABDOMEN:  Obese.  No organomegaly is noted.<br/>
NEURO: A/O x 3, NF, Anxious<br/>
EXTREMITIES:  Show no evidence of cyanosis, clubbing, or calf tenderness. Chronic edema
<br/>
<br/>
<br/> LABORATORY DATA~ <br/>

<table border="1">
	<tbody>
		<tr>
			<th align="left">LabResults</th>
			<td>12/18/2023</td>
			<td>11/20/2023</td>
			<td>10/26/2023</td>
			<td>09/29/2023</td>
			<td>09/01/2023</td>
			<td>08/11/2023</td>
		</tr>
		<tr>
			<th align="left">  CBC</th>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    WBC x 10^3/uL</td>
			<td><br/>
			</td>
			<td>5.4</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    RBC x 10^6/uL</td>
			<td><br/>
			</td>
			<td>3.88 (L)</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    HGB g/dL</td>
			<td><br/>
			</td>
			<td>12.1</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    HCT %</td>
			<td><br/>
			</td>
			<td>37.1</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    MCV fL</td>
			<td><br/>
			</td>
			<td>96 (H)</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    MCH pg</td>
			<td><br/>
			</td>
			<td>31</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    MCHC g/dL</td>
			<td><br/>
			</td>
			<td>32.6</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    RDW %</td>
			<td><br/>
			</td>
			<td>13.4</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    PLT x 10^3/uL</td>
			<td><br/>
			</td>
			<td>183</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Neu %</td>
			<td><br/>
			</td>
			<td>56</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    LY %</td>
			<td><br/>
			</td>
			<td>31</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    MO %</td>
			<td><br/>
			</td>
			<td>7</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    EO %</td>
			<td><br/>
			</td>
			<td>4</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Neu # (ANC) x 10^3/uL</td>
			<td><br/>
			</td>
			<td>3.0</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    BA %</td>
			<td><br/>
			</td>
			<td>2</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    MO # x 10^3/uL</td>
			<td><br/>
			</td>
			<td>0.4</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    EO # x 10^3/uL</td>
			<td><br/>
			</td>
			<td>0.20</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    BA # x 10^3/uL</td>
			<td><br/>
			</td>
			<td>0.1</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    LY # x 10^3/uL</td>
			<td><br/>
			</td>
			<td>1.7</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<th align="left">  ManualDifferential</th>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<th align="left">  Coags</th>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    PT sec</td>
			<td>36.6 (H)</td>
			<td>36.2 (H)</td>
			<td>32.4 (H)</td>
			<td>39.9 (H)</td>
			<td>36.0 (H)</td>
			<td>33.9 (H)</td>
		</tr>
		<tr>
			<td>    INR</td>
			<td>3.10 (H)</td>
			<td>3.00 (H)</td>
			<td>2.70 (H)</td>
			<td>3.30 (H)</td>
			<td>3.00 (H)</td>
			<td>2.80 (H)</td>
		</tr>
		<tr>
			<td>    Target INR</td>
			<td>2-3</td>
			<td>2-3</td>
			<td>2-3</td>
			<td>2.5-3.5</td>
			<td><br/>
			</td>
			<td>2.5-3.5</td>
		</tr>
		<tr>
			<td>    Current Warfarin dose</td>
			<td>7.5 mg W; 5 mg rest</td>
			<td>7.5 mg W; 5 mg rest</td>
			<td>7.5 mg W; 5 mg rest</td>
			<td>7.5 mg Wed; 5 mg rest</td>
			<td><br/>
			</td>
			<td>7.5 mg Wed; 5 mg rest</td>
		</tr>
		<tr>
			<td>    New Warfarin dose</td>
			<td>no change</td>
			<td>no change</td>
			<td>no change</td>
			<td>no change</td>
			<td><br/>
			</td>
			<td>no change</td>
		</tr>
		<tr>
			<th align="left">  Chemistries</th>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Glucose, fasting mg/dL</td>
			<td><br/>
			</td>
			<td>104 (H)</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    BUN mg/dL</td>
			<td><br/>
			</td>
			<td>23</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Creatinine mg/dL</td>
			<td><br/>
			</td>
			<td>0.95</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    BUN/Creatinine ratio</td>
			<td><br/>
			</td>
			<td>SEE NOTE:</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Sodium mmol/L</td>
			<td><br/>
			</td>
			<td>140</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Potassium mmol/L</td>
			<td><br/>
			</td>
			<td>4.2</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Chloride mmol/L</td>
			<td><br/>
			</td>
			<td>107</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    CO2 mmol/L</td>
			<td><br/>
			</td>
			<td>25</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Calcium mg/dL</td>
			<td><br/>
			</td>
			<td>9.7</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Albumin g/dL</td>
			<td><br/>
			</td>
			<td>4.4</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Total protein g/dL</td>
			<td><br/>
			</td>
			<td>7.3</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Globulin g/dL</td>
			<td><br/>
			</td>
			<td>2.9</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    A/G ratio</td>
			<td><br/>
			</td>
			<td>1.5</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Bilirubin, total mg/dL</td>
			<td><br/>
			</td>
			<td>0.6</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Alkaline phosphatase U/L</td>
			<td><br/>
			</td>
			<td>43</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    AST/SGOT U/L</td>
			<td><br/>
			</td>
			<td>14</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    ALT/SGPT U/L</td>
			<td><br/>
			</td>
			<td>10</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    LDH U/L</td>
			<td><br/>
			</td>
			<td>147</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    eGFR, mL/min/1.73</td>
			<td><br/>
			</td>
			<td>67</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Vitamin D, 25-hydroxy ng/mL</td>
			<td><br/>
			</td>
			<td>41</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<th align="left">  TumorMarkers</th>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    CEA ng/mL</td>
			<td><br/>
			</td>
			<td>&lt;2.0</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    CA 27-29 U/mL</td>
			<td><br/>
			</td>
			<td>14</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<th align="left">  AnemiaLabs</th>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Iron, total, mcg/dL</td>
			<td><br/>
			</td>
			<td>67</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Iron binding capacity (TIBC) mcg/dL</td>
			<td><br/>
			</td>
			<td>393</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Ferritin ng/mL</td>
			<td><br/>
			</td>
			<td>39</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Iron, % saturation</td>
			<td><br/>
			</td>
			<td>17</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<th align="left">  Hormones</th>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    T3 uptake %</td>
			<td><br/>
			</td>
			<td>29</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Free thyroxine index</td>
			<td><br/>
			</td>
			<td>2.6</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    TSH, mIU/L</td>
			<td><br/>
			</td>
			<td>1.48</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Thyroxine (T4) ug/dL</td>
			<td><br/>
			</td>
			<td>8.9</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<th align="left">  Pathology/Cytology</th>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<th align="left">  Lab - Other</th>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
	</tbody>
</table>
<br/>
<br/>
<br/>
<br/> RADIOLOGIC DATA~ <br/>
Mammogram 11/22 BIRADS 2<br/>
 <br/>
CT scans of the chest, abdomen, and pelvis are negative for metastatic disease. No pancreatic lesions are noted.<br/>
 <br/>
DEXA scan shows T-score of -1.8 and stable.<br/>
 <br/>
MAMMOGRAM 5/21 BIRADS 2<br/>
 <br/>
COLONOSCOPY 5/21<br/>
 <br/>
MRI BREASTS: 10/20 BIRADS 2<br/>
 <br/>
MAMMOGRAM 10/18/2019: BI-RADS 2.<br/>
 <br/>
Right breast ultrasound and mammogram 12/18/18: BI-RADS category 4, biopsy is recommended.<br/>
 <br/>
10/18 DEXA SCAN STABLE BONE DENSITY<br/>
 <br/>
10/18 CT chest stable lung nodule<br/>
 <br/>
MAMMOGRAM/LEFT BREAST U/S: Cluster microcalcifications in the right breast, spot compressions<br/>
 <br/>
DEXA SCAN T SCORE- 2<br/>
 <br/>
MAMMOGRAM 10/17 BIRADS 2<br/>
 <br/>
CT CHEST: 5 MM LLL NODULE, REST NEGATIVE<br/>
 <br/>
LEFT BREAST U/S: BIRADS 2<br/>
 <br/>
LEFT BREAST MAMMOGRAM 4/17 BIRADS 3<br/>
 <br/>
CT CHEST NOT COMPLETED<br/>
 <br/>
DEXA SCAN 7/15 NORMAL DENSITY<br/>
 <br/>
9/18/14 CT/PET SCAN  seroma left breast with small left axillary adenopathy. small left lung nodule<br/>
 <br/>
ECHO 69%<br/>
 <br/>
BONE SCAN 9/14 NEGATIVE<br/>
<br/>
<br/> PATHOLOGY~ <br/>
LEFT BREAST BX 11/11/22 Fibroadenoma, calcifications<br/>
Pathology from re-excision of the margin on 09/02/2014, shows the left inferior margin is about 5 mm, closest margin, presenting with residual poorly differentiated carcinoma.  The left capsule shows fibrous tissue, one sentinel lymph node is negative. <br/>
<br/>
Excision biopsy dated 08/19/2014, shows poorly differentiated mammary carcinoma measuring 4.7 x 4.2 x 4 cm.  Lymphovascular invasion is not identified.  Lobular carcinoma in situ is not present.  Nipple involvement is negative.  Superior margin and inferior margin negative.  Anterior and medial margins are positive for tumor.  Tumor is ER 11% positive, PR 0% positive, and HER-2/neu negative by SISH.<br/>
<br/>
<br/> GENETIC TESTING~ <br/>
<br/>
<br/>
<br/> NGS PANEL~ <br/>
<br/>
<br/>
<br/> IMPRESSION~ <br/>
<ol><li>AJCC stage T2, N0, M0 invasive poorly differentiated mammary carcinoma of the left breast status post excision followed by re-excision of margins and negative sentinel node biopsy.</li><li>Tumor is ER-positive, PR-negative, HER-2/neu-negative by SISH.</li><li>Completed adjuvant systemic chemotherapy with Adriamycin/Cytoxan followed by weekly Taxol.</li><li>Continue Adjuvant hormonal therapy with Letrozole until 2024.</li><li>Completed left breast radiation therapy, June 2015. BRCA2-positive; refuses bilateral mastectomy.</li><li>Status post benign right breast biopsy, December 2019, November 2022.</li><li>Extreme anxiety and depression.</li><li>History of deep vein thrombosis, right lower extremity, 2005 and 2006. Protein C/S-deficiency, Factor V Leiden-positive and remains on Coumadin therapy.</li><li>Hypertension, hypercholesterolemia, and minimal comorbidities.</li><li>Status post colonoscopy, May 2021. BRCA2-positive. Needs screening for ovarian/pancreatic cancer.</li><li>CT scan of the chest, abdomen, and pelvis 4/22, repeat pre visit</li><li>Stable osteopenia. DEXA scan is due in April 2024. Continue calcium and vitamin D.</li><li>weight gain<br/>
	</li><li>Labs prior to next visit. Family history of colon cancer.</li><li>MRI breast pre visit.</li><li>COVID vaccine completed.</li><li>Non complaint with f/u</li></ol>
<br/>
<br/>
<br/> PLAN~ <br/>
As outlined above.



<br/> NEW ORDERS~ <br/>
Labs: None<br/>
Services: None<br/>


<br/>Imaging: None<br/>
Prescriptions: None<br/>
<br/>


<br/>.<br/>
<br/>


<br/>ANU THUMMALA, MD<br/>
Medical Hematology and Oncology<br/>
<br/>
This document serves as a record of the services and decisions personally performed and made by Anu Thummala, MD. It was created on her behalf by Miranda Puentes, a trained medical scribe. The creation of this document is based on the provider's statements to the medical scribe.<br/>
 <br/>
The information in this document, created by the medical scribe for me, accurately reflects the services I personally performed and the decisions made by me. I have reviewed and approved this document for accuracy prior to leaving the patient care area.<br/>
<br/>


<br/>Send copy of note to: Edward Harding, M.D.<br/>
Maria Villalobos, APRN<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>

<br/>Electronically signed by Anu Thummala MD 01/02/2024 15:14 PST 
		        </p>
		      </li></ul>
</div><br/><br/></body></html>